Font Size
A
A
A
1

Medications and Drugs

Brand Names: Daunoxome

Generic Name: daunorubicin liposomal (Pronunciation: DAW noe ROO bi sin LYE poe SOE mal)

What is daunorubicin liposomal (Daunoxome)?

Daunorubicin liposomal is a cancer (antineoplastic) medication. Daunorubicin liposomal interferes with the growth of cancer cells and slows their growth and spread in the body.

Daunorubicin liposomal is used to treat advanced HIV-associated Kaposi's sarcoma.

Daunorubicin liposomal may also be used for purposes other than those listed in this medication guide.

What are the possible side effects of daunorubicin liposomal (Daunoxome)?

If you experience any of the following serious side effects from daunorubicin liposomal, contact your doctor immediately:

  • an allergic reaction (including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
  • decreased bone marrow function and blood problems (extreme fatigue; easy bruising or bleeding; black, bloody or tarry stools; or fever, chills, or signs of infection);
  • congestive heart failure (difficulty breathing, fluid retention, chest pain);
  • tissue or vein reactions near the site of administration;
  • liver damage (abdominal pain, yellowing of the skin or eyes);
  • nausea, vomiting, diarrhea, or loss of appetite;
  • inflamation or sores inside the mouth, throat, or intestines;
  • numbness or tingling;
  • fever, chills, or other signs of infection; or
  • back pain, flushing, and chest tightness while daunorubicin liposomal is being administered.

Other, less serious side effects may be more likely to occur. Continue taking daunorubicin liposomal and talk to your doctor if you experience:

  • temporary hair loss; or
  • red colored urine for 1 or 2 days following a dose.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may report side effects to FDA at 1-800-FDA-1088.

What is the most important information I should know about daunorubicin liposomal (Daunoxome)?

Daunorubicin liposomal should only be administered under the supervision of a qualified healthcare provider experienced in the use of cancer chemotherapeutic agents.

Serious side effects have been reported with the use of daunorubicin liposomal including: allergic reactions (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives); severe heart damage with prolonged use; decreased bone marrow function and blood problems (extreme fatigue; easy bruising or bleeding; black, bloody or tarry stools; fever or chills; or signs of infection); severe nausea, vomiting, diarrhea, and loss of appetite; and others. Talk to your doctor about the possible side effects from treatment with daunorubicin liposomal.



Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Identifier Tool

Need help identifying pills and medications?
Use the pill finder tool on RxList.



NIH talks about Ebola on WebMD